This policy explains how we use information you give to us and how we protect your privacy.
We're proud to have a brilliant array of high profile supporters who go the extra mile to raise awareness of our work and help us support and campaign for stroke survivors.
Whether it’s taking part in a fundraising run, meeting the people we support, or giving time for media interviews, we would like to thank everyone for being such an important part of our family.
As part of our five-year research strategy we have made a commitment to working with others to achieve a clear vision about the future priorities for stroke research.
We believe in life after stroke. That’s why we actively campaign for better stroke care, working with politicians of all parties to ensure stroke remains high on the political agenda. It's why we fund research into finding new treatments, and also ways of reducing the risk of stroke across the UK. Find out what we're upto across Northern Ireland, Scotland and Wales.
We organise the largest multidisciplinary stroke conference and exhibition in the UK, bringing together professionals from all stages of the stroke pathway to learn the latest developments in research and practice.
On Tuesday 1st September 2015, the Chief Scientist Office and the Stroke Association celebrated their partnership in building stroke research capacity in Scotland with the joint funding of two new research awards.
On February 11, at the International Stroke Conference (ISC 2015 in Nashville, USA) the latest findings were released from four, large studies investigating the effect of treating patients with mechanical clot retrieval.
Find out more about our leadership team and our Trustees.
We currently offer a range of services covering the whole stroke pathway that supports over 60,000 stroke survivors, carers and families every year, to ensure they get the help they need.
Over 3500 delegates attended the 2nd European Stroke Organisation Conference (ESOC 2016) today in Barcelona. Today’s program included teaching courses, scientific presentations, an official welcome from the ESOC President Professor Kennedy Lees and from Professor Angel Chamorro, and presentations from major clinical trials.